Much debate has raged over the impact President Obama’s new universal health care law will have on business. To date, most of the analysis has focused on the impact the rule will have on businesses’ insurance and benefits costs. But a little-known tax-reporting provision in the law could be far more costly and burdensome procurement [...]

[Read more →]

Robert Van Brederode of Ryan (a tax strategy firm that is an Ariba partner) shared his insights into the opportunity and risk posed by VAT at Ariba LIVE in Amsterdam. Robert recommends that companies look beyond income tax since there is “too much money involved” in VAT and customs duties to ignore them.

Justin Fogarty is [...]

[Read more →]

C-SPAN has never been known for their riveting programming line-up. Even die hard political junkies like myself shun the channel these days in favor of alternative sources of news and analysis. But C-SPAN’s value changes dramatically if you can cut out the bloviating and get to the meat of what you would like to see. [...]

[Read more →]

While making fun of the way governments purchase has long been a good source of humor in spend management circles, the deficit news coming out now leads one to believe that it is now time to really make something happen.
What do you think? How would you make this happen? Is it a lost [...]

[Read more →]

On December 30th, the EPA announced plans to place greater restrictions on 4 types of chemicals; phthalates, short-chain chlorinated paraffins, polybrominated diphenyl ethers (PBDEs) and perfluorinated chemicals. To quote the EPA’s press release:
EPA intends to establish a “Chemicals of Concern” list and is beginning a process that may lead to regulations requiring significant risk [...]

[Read more →]